This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Genomic Health Inc (GHDX)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 275.71M 261.60M 235.17M 206.11M
Cost of Sales 41.87M 35.78M 31.55M 26.52M
Gross Operating Profit 233.83M 225.82M 203.63M 179.59M
Selling, General, and Administrative Expenses 194.53M 164.99M 140.62M 124.16M
Research & Development 56.06M 66.33M 49.10M 39.86M
Operating Income before D & A (EBITDA) -16.76M -5.51M 13.90M 15.57M
Depreciation & Amortization 6.87M 6.32M 5.47M 7.31M
Interest Income 192.00K 222.00K 295.00K 221.00K
Other Income - Net -764.00K -801.00K -58.00K -205.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -24.20M -12.41M 8.67M 8.28M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -24.20M -12.41M 8.67M 8.28M
Income Taxes 393.00K 346.00K 422.00K 429.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -24.59M -12.76M 8.25M 7.85M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -24.59M -12.76M 8.25M 7.85M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -24.59M -12.76M 8.25M 7.85M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-24.59M -12.76M 8.25M 7.85M
Preferred Dividends
Net Income Available To Common -24.59M -12.76M 8.25M 7.85M
Basic EPS from Continuing Ops. -0.78 -0.42 0.27 0.27
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.78 -0.42 0.27 0.27
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.78 -0.42 0.27 0.27
Basic Normalized Net Income/Share -0.78 -0.42 0.27 0.27
EPS fr Continuing Ops. -0.78 -0.42 0.26 0.26
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.78 -0.42 0.26 0.26
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.78 -0.42 0.26 0.26
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.78 -0.42 0.26 0.26
Dividends Paid per Share 0.00 0.00 0.00 0.00
GHDX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

GHDX Genomic Health Inc

Chart of GHDX

Analysts Ratings for GHDX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 6 5 4
Moderate Buy 1 1 1 1
Hold 4 3 4 5
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
GET GHDX ANALYST REPORT

GHDX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs